Nov 13 2015 |
Brazilian Patent and Trademark Office Publishes New Rule on Prioritization Examination of Patent Applications |
Michael Best & Friedrich LLP |
Nov 30 2015 |
Biologics and Biosimilar Bits and Bytes – November 30, 2015 |
Michael Best & Friedrich LLP |
Jan 8 2016 |
January 8, 2016 -- Biologics and Biosimilars Bits and Bytes |
Michael Best & Friedrich LLP |
Jan 20 2014 |
BRIC-a-BRAC January 20, 2014: News Items from BRIC Countries |
Michael Best & Friedrich LLP |
May 2 2016 |
U.S. Supreme Court Listens to Oral Arguments Regarding Claim Construction and Appellate Review of Institution Decisions in AIA Trials |
Michael Best & Friedrich LLP |
Mar 12 2014 |
Settlement Does Not Guarantee Termination of IPR (Inter Partes Review) Proceedings |
Michael Best & Friedrich LLP |
Jul 16 2014 |
The Thorny Problem of Patentable Eligible Subject Matter: Part 4 of a 10-Part Series: Russia |
Michael Best & Friedrich LLP |
Nov 6 2016 |
New Requirements in Brazil for Plant Variety Protection Applications in View of Brazil’s Biodiversity Law |
Michael Best & Friedrich LLP |
Jan 16 2017 |
Two Important Decisions Addressing ANVISA’s Prior Approval of Pharmaceutical Patents in Brazil |
Michael Best & Friedrich LLP |
May 2 2017 |
Federal Circuit Rules That Public Sales Trigger the AIA On-Sale Bar Even If Claimed Features Are Not Publicly Disclosed |
Michael Best & Friedrich LLP |
Dec 8 2014 |
The Breadth of India’s “Bolar Exemption” |
Michael Best & Friedrich LLP |
Jan 29 2015 |
Post-Grant Review Offers Expanded Opportunity For Challenging American Invents Act (AIA) Patents |
Michael Best & Friedrich LLP |
Dec 13 2010 |
USPTO Introduces Program that Allows Deferral of Patent Application Filing Fees |
Michael Best & Friedrich LLP |
Jul 6 2011 |
Keeping Your Trademarks From Becoming XXX-Rated |
Michael Best & Friedrich LLP |
Mar 11 2012 |
Social Media: Reap the Rewards While Avoiding the Pitfalls |
Michael Best & Friedrich LLP |
Jul 21 2012 |
Patent Office Finalizes Rules on Preissuance Submissions by Third Parties |
Michael Best & Friedrich LLP |
Oct 27 2012 |
Abandonment and Revival of U.S. Patent Application |
Michael Best & Friedrich LLP |
Oct 14 2015 |
A Review of the Patent Related Provisions of the TPP – Patentable Subject Matter and Grace Periods |
Michael Best & Friedrich LLP |
Mar 1 2013 |
Brand Owners Can Register Trademarks for Protection Mechanisms in New Generic Top-Level Domain (gTLDs) |
Michael Best & Friedrich LLP |
Dec 14 2015 |
Merck’s Ezetrol and Patent Term Extension in Israel |
Michael Best & Friedrich LLP |
May 19 2013 |
Prioritization of Examination of Patent Applications in Brazil for Pharmaceutical Products and Processes, and Devices and Equipment Related to Public Health |
Michael Best & Friedrich LLP |
Aug 9 2013 |
Recent Decisions involving Section 3(d) of the Indian Patents Act |
Michael Best & Friedrich LLP |
Feb 16 2016 |
Brazilian Patent Office and Patent Prosecution Highway Program |
Michael Best & Friedrich LLP |
Sep 10 2013 |
Understanding Biologics and Biosimilars in Brazil |
Michael Best & Friedrich LLP |
Mar 22 2016 |
Supreme Court Agrees to Review the Appropriate Measure of Design Patent Damages |
Michael Best & Friedrich LLP |
Feb 24 2014 |
Patent Trolls: A View from Europe |
Michael Best & Friedrich LLP |
May 6 2016 |
International Trade Commission Invalidates Patents to Fitness Monitoring Systems as Ineligible under § 101 |
Michael Best & Friedrich LLP |
Jun 14 2016 |
Supreme Court Relaxes Standard for Enhancing Patent Damages in Halo Electronics, Inc. v. Pulse Electronics, Inc. |
Michael Best & Friedrich LLP |
Jun 5 2014 |
Supreme Court Paves the Way for Invalidating Vague Patents |
Michael Best & Friedrich LLP |
Jun 18 2014 |
Trademark Trial and Appeal Board Cancels Six REDSKINS Trademark Registrations |
Michael Best & Friedrich LLP |
Dec 7 2016 |
Supreme Court Holds Profit from Components of Infringing Product Can Be Appropriate Measure of Design Patent Damages |
Michael Best & Friedrich LLP |
Apr 10 2017 |
Brazil: Courts Confirm Preliminary Injunction Based on Pending Patent Applications |
Michael Best & Friedrich LLP |
Jun 21 2017 |
Central District of California Analyzes Equitable Estoppel and Laches in View of Supreme Court’s Recent Laches Ruling |
Michael Best & Friedrich LLP |
Feb 16 2015 |
Australia – A Further Update: The Thorny Problem of Patentable Eligible Subject Matter: Part 8 of a 10-Part Series |
Michael Best & Friedrich LLP |
Apr 28 2015 |
Approval of First Biosimilar Monoclonal Antibody in Brazil |
Michael Best & Friedrich LLP |
Sep 2 2012 |
Patent Reform – What You Need to Know for the Approaching September 16, 2012 Implementation Date |
Michael Best & Friedrich LLP |
Nov 22 2015 |
Trans-Pacific Partnership and the Continuing Controversy Over the Exclusivity Period for Biologics |
Michael Best & Friedrich LLP |
Dec 10 2015 |
Biologics and Biosimilars Bits and Bytes – December 10, 2015 |
Michael Best & Friedrich LLP |
Jun 8 2013 |
Section 3(d) of the Indian Patents Act – Part I |
Michael Best & Friedrich LLP |
Aug 29 2013 |
Section 8 of the Indian Patents Act and a Comparison with the Disclosure Requirements in Canada, Israel and the U.S. |
Michael Best & Friedrich LLP |
Jan 15 2014 |
Time Period and Burden of Proof Requirements when Requesting Revocation of a Patent in Kenya |
Michael Best & Friedrich LLP |
Jun 3 2016 |
An Overview of the USTR’s 2016 Special 301 Report on the State of IPR in Chile |
Michael Best & Friedrich LLP |
Apr 10 2014 |
The Copaxone Story in the U.S. and India: A Further Update |
Michael Best & Friedrich LLP |
Apr 23 2014 |
The Copaxone Story in the U.S. and India: To Stay or Not to Stay is the Question |
Michael Best & Friedrich LLP |
Jun 30 2016 |
Overview of USTR’s 2016 Special 301 Report on State of Inter Partes Review in Argentina |
Michael Best & Friedrich LLP |
Jul 13 2016 |
Federal Circuit Clarifies When an Invention is the Subject of a Commercial Sale or Offer for Sale for Purposes of the On-Sale Bar |
Michael Best & Friedrich LLP |
Jun 20 2014 |
Availability of Biosimilar Pathways and Data/Marketing Exclusivity Globally: Update |
Michael Best & Friedrich LLP |
Aug 28 2014 |
The Thorny Problem of Patentable Eligible Subject Matter: Part 8 of a 10-Part Series: Australia |
Michael Best & Friedrich LLP |
Sep 22 2014 |
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 1 of a 5-Part Series |
Michael Best & Friedrich LLP |
Oct 14 2014 |
First Mailbox Appeal to be decided by the Federal Court of Appeals in Brazil |
Michael Best & Friedrich LLP |